130 related articles for article (PubMed ID: 22469661)
1. Perfluorinated compounds may lower vaccine protection in children.
Potera C
Environ Health Perspect; 2012 Apr; 120(4):A150-1. PubMed ID: 22469661
[No Abstract] [Full Text] [Related]
2. Serum vaccine antibody concentrations in children exposed to perfluorinated compounds.
Grandjean P; Andersen EW; Budtz-Jørgensen E; Nielsen F; Mølbak K; Weihe P; Heilmann C
JAMA; 2012 Jan; 307(4):391-7. PubMed ID: 22274686
[TBL] [Abstract][Full Text] [Related]
3. Perfluorinated compounds and immunotoxicity in children.
Zobel LR; Olsen GW; Butenhoff JL
JAMA; 2012 May; 307(18):1910; author reply 1910-1. PubMed ID: 22570452
[No Abstract] [Full Text] [Related]
4. Estimated exposures to perfluorinated compounds in infancy predict attenuated vaccine antibody concentrations at age 5-years.
Grandjean P; Heilmann C; Weihe P; Nielsen F; Mogensen UB; Timmermann A; Budtz-Jørgensen E
J Immunotoxicol; 2017 Dec; 14(1):188-195. PubMed ID: 28805477
[TBL] [Abstract][Full Text] [Related]
5. [Persistant perfluorinated compounds cause immunotoxic effects].
Heilmann C; Jensen L; Weihe P; Nielsen F; Knudsen LE; Budtz-Jørgensen E; Mølbak K; Grandjean P
Ugeskr Laeger; 2014 Feb; 176(9A):V09130572. PubMed ID: 25350410
[TBL] [Abstract][Full Text] [Related]
6. [A comparative evaluation of the immunological efficacy of ADPT vaccine and ADT-M anatoxin in the immunization of children against diphtheria and tetanus].
Rusakova EV; Bezuglova MS; Vasil'eva VI; Frank KD; Panina GM
Zh Mikrobiol Epidemiol Immunobiol; 1991 Jul; (7):52-5. PubMed ID: 1950266
[TBL] [Abstract][Full Text] [Related]
7. Serum Vaccine Antibody Concentrations in Adolescents Exposed to Perfluorinated Compounds.
Grandjean P; Heilmann C; Weihe P; Nielsen F; Mogensen UB; Budtz-Jørgensen E
Environ Health Perspect; 2017 Jul; 125(7):077018. PubMed ID: 28749778
[TBL] [Abstract][Full Text] [Related]
8. Persistence of humoral immunity to tetanus and diphtheria in hematopoietic stem cell transplant recipients after post-transplant immunization.
Škovránková J; Petráš M
Pediatr Blood Cancer; 2012 Nov; 59(5):908-13. PubMed ID: 22514148
[TBL] [Abstract][Full Text] [Related]
9. [Vaccination against diphtheria and tetanus of children with thymus hyperplasia syndrome].
Ozeretskovskiĭ NA; Martynova MI; Shishatskaia SN; Kova'lskaia SIa; Veĭsfeĭler OIu; Vaganov PD; Mikheeva IG
Pediatriia; 1989; (9):26-31. PubMed ID: 2587163
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of the immunological effectiveness of the planned vaccinal prophylaxis of diphtheria and tetanus in Sverdlovsk and Sverdlovsk Province].
Ivchenko SI; Basova NN; Kondrashova ZN
Zh Mikrobiol Epidemiol Immunobiol; 1986 Jun; (6):15-9. PubMed ID: 2944328
[TBL] [Abstract][Full Text] [Related]
11. [The antidiphtheria and antitetanus immunities of children of the Maritime Territory after the use of adsorbed DTP vaccine and adsorbed DT-m anatoxin].
Zaporzhets TS; Lunika IG; Greben'kova LK; Belogolovkina NA; Makarenkova ID; Besednova NN
Zh Mikrobiol Epidemiol Immunobiol; 1999; (2):57-9. PubMed ID: 10356739
[TBL] [Abstract][Full Text] [Related]
12. [Characteristics of dynamics of antibody formation in children with chronic tonsillitis and adenoid hypertrophy immunized with the anti-pertussis-diphtheria-tetanus vaccine].
Giulling EV; Voloshchuk MI; Chernata LI; Belen'kaia LV
Zh Ushn Nos Gorl Bolezn; 1978; (6):50-3. PubMed ID: 735359
[No Abstract] [Full Text] [Related]
13. The immunization of children with combined diphtheria and tetanus vaccine in Sweden.
Larsen K; Ullberg-Olsson K; Wickbom B; Hederstedt B
J Biol Stand; 1987 Apr; 15(2):103-7. PubMed ID: 3597445
[TBL] [Abstract][Full Text] [Related]
14. [An evaluation of the epidemiological and immunological efficacy of the vaccinal prophylaxis of diphtheria and tetanus].
Kriukov VI; Bolotovskiĭ VM; Mikheeva IV; Zakharova TR; Basova NN; Ruut IuK; Iurevits LV; Adamenko RG; Raupov BE
Zh Mikrobiol Epidemiol Immunobiol; 1994; (3):57-61. PubMed ID: 7941870
[TBL] [Abstract][Full Text] [Related]
15. Antibody level of New Zealand children immunized with the triple vaccine DTP (diphtheria-tetanus-pertussis).
Lau RC
Epidemiol Infect; 1988 Oct; 101(2):405-10. PubMed ID: 2903065
[TBL] [Abstract][Full Text] [Related]
16. Antibody production following immunization with diphtheria and tetanus toxoids in children receiving chemotherapy during remission of malignant disease.
Kung FH; Orgel HA; Wallace WW; Hamburger RN
Pediatrics; 1984 Jul; 74(1):86-9. PubMed ID: 6588361
[TBL] [Abstract][Full Text] [Related]
17. [Immunological effectiveness of a 2d revaccination against diphtheria performed at intervals extended up to 7-10 years].
Maksimova NM; Sukhorukova NL; Finkel' MP
Zh Mikrobiol Epidemiol Immunobiol; 1987 May; (5):50-4. PubMed ID: 3497501
[TBL] [Abstract][Full Text] [Related]
18. Booster response to the tetanus and diphtheria toxoid carriers of 11-valent pneumococcal conjugate vaccine in adults and toddlers.
Olander RM; Wuorimaa T; Käyhty H; Leroy O; Dagan R; Eskola J
Vaccine; 2001 Nov; 20(3-4):336-41. PubMed ID: 11672895
[TBL] [Abstract][Full Text] [Related]
19. Immunity and immunization of children against diphtheria in Sweden.
Mark A; Christenson B; Granström M; Strandell A; Wickbom B; Böttiger M
Eur J Clin Microbiol Infect Dis; 1989 Mar; 8(3):214-9. PubMed ID: 2496989
[TBL] [Abstract][Full Text] [Related]
20. [Intracutaneous test with tetanus toxoid--a possibility for evaluating cellular immune reaction].
Schöntube M; Thilo W; Schmitz HH
Padiatr Grenzgeb; 1986; 25(2-3):275-81. PubMed ID: 3487763
[No Abstract] [Full Text] [Related]
[Next] [New Search]
